Biliary and Pancreatic Tract

  • 3E0J3 - Percutaneous
    • 3E0J30
      • 3E0J304 - Introduction Biliary and Pancreatic Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Percutaneous Approach
      • 3E0J305 - Introduction Biliary and Pancreatic Tract to Other Antineoplastic with Antineoplastic, Percutaneous Approach
      • 3E0J30M - Introduction Biliary and Pancreatic Tract to Monoclonal Antibody with Antineoplastic, Percutaneous Approach
    • 3E0J32
      • 3E0J328 - Introduction Biliary and Pancreatic Tract to Oxazolidinones with Anti-infective, Percutaneous Approach
      • 3E0J329 - Introduction Biliary and Pancreatic Tract to Other Anti-infective with Anti-infective, Percutaneous Approach
    • 3E0J33
      • 3E0J33Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Anti-inflammatory, Percutaneous Approach
    • 3E0J36
      • 3E0J36Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Nutritional Substance, Percutaneous Approach
    • 3E0J37
      • 3E0J37Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Electrolytic and Water Balance Substance, Percutaneous Approach
    • 3E0J3B
      • 3E0J3BZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Anesthetic Agent, Percutaneous Approach
    • 3E0J3G
      • 3E0J3GC - Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Percutaneous Approach
    • 3E0J3H
      • 3E0J3HZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Radioactive Substance, Percutaneous Approach
    • 3E0J3K
      • 3E0J3KZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Other Diagnostic Substance, Percutaneous Approach
    • 3E0J3N
      • 3E0J3NZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Percutaneous Approach
    • 3E0J3S
      • 3E0J3SF - Introduction Biliary and Pancreatic Tract to Other Gas with Gas, Percutaneous Approach
    • 3E0J3T
      • 3E0J3TZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Destructive Agent, Percutaneous Approach
    • 3E0J3U
      • 3E0J3U0 - Introduction Biliary and Pancreatic Tract to Autologous with Pancreatic Islet Cells, Percutaneous Approach
      • 3E0J3U1 - Introduction Biliary and Pancreatic Tract to Nonautologous with Pancreatic Islet Cells, Percutaneous Approach
  • 3E0J4 - Percutaneous Endoscopic
    • 3E0J4G
      • 3E0J4GC - Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Percutaneous Endoscopic Approach
  • 3E0J7 - Via Natural or Artificial Opening
    • 3E0J70
      • 3E0J704 - Introduction Biliary and Pancreatic Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Approach
      • 3E0J705 - Introduction Biliary and Pancreatic Tract to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Approach
      • 3E0J70M - Introduction Biliary and Pancreatic Tract to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Approach
    • 3E0J72
      • 3E0J728 - Introduction Biliary and Pancreatic Tract to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Approach
      • 3E0J729 - Introduction Biliary and Pancreatic Tract to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Approach
    • 3E0J73
      • 3E0J73Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Approach
    • 3E0J76
      • 3E0J76Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Approach
    • 3E0J77
      • 3E0J77Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Approach
    • 3E0J7B
      • 3E0J7BZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Approach
    • 3E0J7G
      • 3E0J7GC - Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Approach
    • 3E0J7H
      • 3E0J7HZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Approach
    • 3E0J7K
      • 3E0J7KZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Approach
    • 3E0J7N
      • 3E0J7NZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Approach
    • 3E0J7S
      • 3E0J7SF - Introduction Biliary and Pancreatic Tract to Other Gas with Gas, Via Natural or Artificial Opening Approach
    • 3E0J7T
      • 3E0J7TZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Approach
    • 3E0J7U
      • 3E0J7U0 - Introduction Biliary and Pancreatic Tract to Autologous with Pancreatic Islet Cells, Via Natural or Artificial Opening Approach
      • 3E0J7U1 - Introduction Biliary and Pancreatic Tract to Nonautologous with Pancreatic Islet Cells, Via Natural or Artificial Opening Approach
  • 3E0J8 - Via Natural or Artificial Opening Endoscopic
    • 3E0J80
      • 3E0J804 - Introduction Biliary and Pancreatic Tract to Liquid Brachytherapy Radioisotope with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach
      • 3E0J805 - Introduction Biliary and Pancreatic Tract to Other Antineoplastic with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach
      • 3E0J80M - Introduction Biliary and Pancreatic Tract to Monoclonal Antibody with Antineoplastic, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J82
      • 3E0J828 - Introduction Biliary and Pancreatic Tract to Oxazolidinones with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach
      • 3E0J829 - Introduction Biliary and Pancreatic Tract to Other Anti-infective with Anti-infective, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J83
      • 3E0J83Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Anti-inflammatory, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J86
      • 3E0J86Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Nutritional Substance, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J87
      • 3E0J87Z - Introduction Biliary and Pancreatic Tract to No Qualifier with Electrolytic and Water Balance Substance, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J8B
      • 3E0J8BZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Anesthetic Agent, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J8G
      • 3E0J8GC - Introduction Biliary and Pancreatic Tract to Other Substance with Other Therapeutic Substance, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J8H
      • 3E0J8HZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Radioactive Substance, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J8K
      • 3E0J8KZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Other Diagnostic Substance, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J8N
      • 3E0J8NZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Analgesics, Hypnotics, Sedatives, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J8S
      • 3E0J8SF - Introduction Biliary and Pancreatic Tract to Other Gas with Gas, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J8T
      • 3E0J8TZ - Introduction Biliary and Pancreatic Tract to No Qualifier with Destructive Agent, Via Natural or Artificial Opening Endoscopic Approach
    • 3E0J8U
      • 3E0J8U0 - Introduction Biliary and Pancreatic Tract to Autologous with Pancreatic Islet Cells, Via Natural or Artificial Opening Endoscopic Approach
      • 3E0J8U1 - Introduction Biliary and Pancreatic Tract to Nonautologous with Pancreatic Islet Cells, Via Natural or Artificial Opening Endoscopic Approach